{"id":46858,"date":"2018-10-05T09:13:35","date_gmt":"2018-10-05T13:43:35","guid":{"rendered":"https:\/\/piel-l.org\/blog\/?p=46858"},"modified":"2018-10-08T12:23:02","modified_gmt":"2018-10-08T16:53:02","slug":"colagenopatia-edicion-no-432-caso-clinico","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/46858","title":{"rendered":"Colagenopat\u00eda Edici\u00f3n N\u00ba 432: Caso cl\u00ednico"},"content":{"rendered":"

Paciente femenina de 36 a\u00f1os de edad, que presenta LES con m\u00e1s de 5 a\u00f1os de evoluci\u00f3n en tratamiento no controlado<\/p>\n

Est\u00e1 tomando:
\n– Hidroxicloroquina 400 mg\/d desde hace 4 a\u00f1os, cumpliendo la toma en forma no continua debido a la escasez de recursos para adquirirlo<\/p>\n

– Durante los meses de verano nota oscurecimientoy agravamiento de las lesiones de cara, pabellones auriculares(Foto n\u00ba1-2) y tronco.(Foton\u00ba3)<\/p>\n

\"\"<\/p>\n

– Hace 5 meses aparecen simult\u00e1neamente nuevas lesiones en dorso de ambas manos, sitio donde nota fragilidad de la piel, discrom\u00edas, peque\u00f1as ampollas, cicatrices y quistes.(Fotos n\u00ba4-5)123<\/p>\n

<\/div>\n

<\/i> VER CASO COMPLETO<\/span><\/a><\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Paciente femenina de 36 a\u00f1os de edad, que presenta LES con m\u00e1s de 5 a\u00f1os de evoluci\u00f3n en
\ntratamiento no controlado<\/p>\n","protected":false},"author":51,"featured_media":46859,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[317],"tags":[],"class_list":["post-46858","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-colagenopatia-al-dia"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/46858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/51"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=46858"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/46858\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media\/46859"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=46858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=46858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=46858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}